Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
NCT ID: NCT04929457
Last Updated: 2023-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
30000 participants
OBSERVATIONAL
2021-09-01
2033-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial
NCT05758779
Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic
NCT05638022
Atherosclerosis in Familial Hypercholesterolemia
NCT02489253
Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NCT05614219
Causes and Natural History of Dyslipidemias
NCT00353782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals screened for Familial Hypercholesterolemia
Individuals participating in diagnostic activities in the digiphysical health care screening program for Familial Hypercholesterolemia and have provided informed consent are included in the cohort.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonas Brinck
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonas Brinck, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Medicine Huddinge H7, Karolinska Institute, Stockholm
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska university hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DigiLipids
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.